Intra-Cellular Therapies, Inc.Equity-NMS: ITCI
Equity-NMS: ITCI
$71.56
+1.40
(26 Feb)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$71.56
Open
$71.56
Today’s high
$71.61
Today’s low
$67.53
52W low
$42.01
52W high
$76.11
1Y
47.33%
5Y
38.41%
Shares O/S
96.81M
Market cap
6.93B
Insights
No insights found for this stock
Compare with other stock
Price
1D
PE
Market cap
About Intra-Cellular Therapies, Inc.

Intra-Cellular Therapies, Inc. is a biopharmaceutical company. The Company is focused on the discovery, clinical development and commercialization of small molecule drugs that address underserved medical needs primarily in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system (CNS).

The Company’s product CAPLYTA is a treatment for depressive episodes associated with bipolar I or II disorder (bipolar depression) in adults as monotherapy and as adjunctive therapy with lithium or valproate. The efficacy of CAPLYTA 42 mg in bipolar depression was demonstrated in two positive Phase III placebo-controlled bipolar depression studies, which evaluated the effects of CAPLYTA on depression in adult patients with bipolar I or bipolar II disorder both as monotherapy (Study 404) and as adjunctive therapy with lithium or valproate (Study 402). .


FAQs

Can I buy Intra-Cellular Therapies, Inc. shares in India?
How to buy Intra-Cellular Therapies, Inc. shares in India?
What is the share price of Intra-Cellular Therapies, Inc.?
What is the Market Capitalization of Intra-Cellular Therapies, Inc.?
What is the PE ratio of Intra-Cellular Therapies, Inc.?
Is Intra-Cellular Therapies, Inc. a good stock to buy?
In which sector / industry does Intra-Cellular Therapies, Inc. operate?